By Professor Andrew Stewart Day

Journal articles

Lawley M; Wu JW; Navas-López VM; Huynh HQ; Carroll MW; Chen M; Medvedev P; Day AS; Hussey S; Sigall-Boneh R; Levine A; Wine E, 2018, 'Global Variation in Use of Enteral Nutrition for Pediatric Crohn Disease', Journal of pediatric gastroenterology and nutrition, 67, pp. e22 - e29, http://dx.doi.org/10.1097/MPG.0000000000001946

Wall CL; Gearry RB; Day AS, 2018, 'Erratum: Treatment of active Crohn's disease with exclusive and partial enteral nutrition: A pilot study in adults (Inflammatory Intestinal Diseases (2018) 2: 4 (219-227) DOI: 10.1159/000489630)', Inflammatory Intestinal Diseases, 2, pp. 236, http://dx.doi.org/10.1159/000491914

Wall CL; Gearry RB; Day AS, 2018, 'Treatment of Active Crohn's Disease with Exclusive and Partial Enteral Nutrition: A Pilot Study in Adults', Inflammatory Intestinal Diseases, 2, pp. 219 - 227, http://dx.doi.org/10.1159/000489630

Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS, 2018, 'Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results from the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. e122 - e126, http://dx.doi.org/10.1097/MPG.0000000000001806

Shaoul R; Brown S; Day AS, 2018, 'Reasoning beyond the Potential Use of Exclusive Enteral Nutrition and Other Specified Diets in Children with Ulcerative Colitis', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. 378 - 382, http://dx.doi.org/10.1097/MPG.0000000000001785

Lopez RN; Appleton L; Gearry RB; Day AS, 2018, 'Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. e45 - e50, http://dx.doi.org/10.1097/MPG.0000000000001688

Day AS; Gulati AS; Patel N; Boyle B; Park KT; Saeed SA, 2018, 'The Role of Combination Therapy in Pediatric Inflammatory Bowel Disease: A Clinical Report from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition', Journal of Pediatric Gastroenterology and Nutrition, 66, pp. 361 - 368, http://dx.doi.org/10.1097/MPG.0000000000001850

Galgut BJ; Lemberg DA; Day AS; Leach ST, 2018, 'The value of fecal markers in predicting relapse in inflammatory bowel diseases', Frontiers in Pediatrics, 5, pp. 292, http://dx.doi.org/10.3389/fped.2017.00292

Garg M; Leach ST; Pang T; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2018, 'Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old', Journal of Cystic Fibrosis, 17, pp. 109 - 113, http://dx.doi.org/10.1016/j.jcf.2017.07.011

Garg M; Leach ST; Day AS; Ooi CY, 2018, 'Fecal calprotectin concentrations in young children with cystic fibrosis: Authors response', Journal of Cystic Fibrosis, 17, pp. e10 - e11, http://dx.doi.org/10.1016/j.jcf.2017.10.012

Day AS, 2018, 'Re: American Gastroenterological Association Institute guideline on therapeutic drug monitoring in inflammatory bowel disease', Translational Pediatrics, 7, pp. 11 - 13, http://dx.doi.org/10.21037/tp.2017.12.03

Day AS, 2018, 'The impact of exclusive enteral nutrition on the intestinal microbiota in inflammatory bowel disease', AIMS Microbiology, 4, pp. 584 - 593, http://dx.doi.org/10.3934/MICROBIOL.2018.4.584

Nazari A; Khorramdelazad H; Hassanshahi G; Day AS; Sardoo AM; Fard ET; Abedinzadeh M; Nadimi AE, 2017, 'S100A12 in renal and cardiovascular diseases', Life Sciences, 191, pp. 253 - 258, http://dx.doi.org/10.1016/j.lfs.2017.10.036

Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI, 2017, 'Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse', Gastrointestinal Endoscopy, 86, pp. 1070 - 1078, http://dx.doi.org/10.1016/j.gie.2017.09.011

Wall CL; Gearry RB; Day AS, 2017, 'New Zealand gastroenterologists’ perceptions, knowledge and experience of exclusive enteral nutrition to treat crohn’s disease', New Zealand Medical Journal, 130, pp. 77 - 79

Splawski JB; Pffefferkorn MD; Schaefer ME; Day AS; Soldes OS; Ponsky TA; Stein P; Kaplan JL; Saeed SA, 2017, 'NASPGHAN Clinical Report on Postoperative Recurrence in Pediatric Crohn Disease', Journal of Pediatric Gastroenterology and Nutrition, 65, pp. 475 - 486, http://dx.doi.org/10.1097/MPG.0000000000001606

Holtman GA; Lisman-van Leeuwen Y; Day AS; Fagerberg UL; Henderson P; Leach ST; Perminow G; Mack D; Van Rheenen PF; Van De Vijver E; Wilson DC; Reitsma JB; Berger MY, 2017, 'Use of laboratory markers in addition to symptoms for diagnosis of inflammatory bowel disease in children: A meta-analysis of individual patient data', JAMA Pediatrics, 171, pp. 984 - 991, http://dx.doi.org/10.1001/jamapediatrics.2017.1736

Day AS; Brown SC, 2017, 'The adjunctive role of nutritional therapy in the management of phlegmon in two children with Crohn's disease', Frontiers in Pediatrics, 5, http://dx.doi.org/10.3389/fped.2017.00199

Day AS; Leach ST; Lemberg DA, 2017, 'An update on diagnostic and prognostic biomarkers in inflammatory bowel disease', Expert Review of Molecular Diagnostics, 17, pp. 835 - 843, http://dx.doi.org/10.1080/14737159.2017.1364160

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Pang T; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. 631 - 636, http://dx.doi.org/10.1016/j.jcf.2017.03.010

McCombie A; Gearry RB; Lopez RN; Lönnfors S; Day AS, 2017, 'Enhancements in Confidence, Acceptance, and Friendship at a Summer Camp for Children with Inflammatory Bowel Disease', Journal of Pediatric Gastroenterology and Nutrition, 65, pp. 311 - 313, http://dx.doi.org/10.1097/MPG.0000000000001526

Flores SE; Aitchison A; Day AS; Keenan JI, 2017, 'Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells', PLoS ONE, 12, http://dx.doi.org/10.1371/journal.pone.0184026

Day AS; Mylvaganam G; Shalloo N; Clarkson C; Leach ST; Lemberg DA, 2017, 'Assessment of disease-specific knowledge in Australian children with inflammatory bowel disease and their parents', Journal of Paediatrics and Child Health, 53, pp. 778 - 781, http://dx.doi.org/10.1111/jpc.13544

Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS, 2017, 'Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study', Inflammatory Bowel Diseases, 23, pp. 1418 - 1424, http://dx.doi.org/10.1097/MIB.0000000000001138

Day AS; Adamji M, 2017, 'Commentary: Impact of fecal calprotectin measurement on decision-making in children with inflammatory bowel disease', Frontiers in Pediatrics, 5, http://dx.doi.org/10.3389/fped.2017.00133

Alhagamhmad MH; Lemberg DA; Day AS; Tan LZ; Ooi CY; Krishnan U; Gupta N; Munday JS; Leach ST, 2017, 'Advancing nutritional therapy: A novel polymeric formulation attenuates intestinal inflammation in a murine colitis model and suppresses pro-inflammatory cytokine production in ex-vivo cultured inflamed colonic biopsies', Clinical Nutrition, 36, pp. 497 - 505, http://dx.doi.org/10.1016/j.clnu.2016.01.010

Bowden MR; Ee LC; Krishnan U; O'Loughlin EV; Hardikar W; Carmody D; Hainsworth C; Jermyn V; Lee MM; Sawyer J; Stormon M; Holmes K; Lemberg DA; Day AS; Paul C; Hazell P, 2017, 'Family impact and infant emotional outcomes following diagnosis of serious liver disease or transplantation in infancy', Journal of Pediatric Gastroenterology and Nutrition, 64, pp. 528 - 532, http://dx.doi.org/10.1097/MPG.0000000000001404

Budd GR; Aitchison A; Day AS; Keenan JI, 2017, 'The effect of polymeric formula on enterocyte differentiation', Innate Immunity, 23, pp. 240 - 248, http://dx.doi.org/10.1177/1753425916689333

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2017, 'Exploring and enhancing the anti-inflammatory properties of polymeric formula', Journal of Parenteral and Enteral Nutrition, 41, pp. 436 - 445, http://dx.doi.org/10.1177/0148607115625627

Lopez RN; Leach ST; Lemberg DA; Duvoisin G; Gearry RB; Day AS, 2017, 'Fecal biomarkers in inflammatory bowel disease', Journal of Gastroenterology and Hepatology (Australia), 32, pp. 577 - 582, http://dx.doi.org/10.1111/jgh.13611

Nightingale S; Stormon MO; O'Loughlin EV; Shun A; Thomas G; Benchimol EI; Day AS; Adams S; Shi E; Ooi CY; Kamath BM; Fecteau A; Langer JC; Roberts EA; Ling SC; Ng VL, 2017, 'Early Posthepatoportoenterostomy Predictors of Native Liver Survival in Biliary Atresia', Journal of Pediatric Gastroenterology and Nutrition, 64, pp. 203 - 209, http://dx.doi.org/10.1097/MPG.0000000000001289

Chae A; Aitchison A; Day AS; Keenan JI, 2017, 'Bovine colostrum demonstrates anti-inflammatory and antibacterial activity in in vitro models of intestinal inflammation and infection', Journal of Functional Foods, 28, pp. 293 - 298, http://dx.doi.org/10.1016/j.jff.2016.11.016

Duvoisin G; Lopez RN; Day AS; Lemberg DA; Gearry RB; Leach ST, 2017, 'Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease', Mediators of Inflammation, 2017, pp. 1936315, http://dx.doi.org/10.1155/2017/1936315

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'Age-Dependent Values of Fecal Calprotectin in Cystic Fibrosis and Healthy Controls', Gastroenterology, 152, pp. S645 - S645, http://dx.doi.org/10.1016/s0016-5085(17)32281-3

Garg M; Leach ST; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2017, 'Determining the Age-Related Levels of Fecal M2-Pyruvate Kinase in Children with Cystic Fibrosis During the First Decade of Life', Gastroenterology, 152, pp. S645 - S646, http://dx.doi.org/10.1016/s0016-5085(17)32282-5

Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY, 2017, 'EPS3.1 Age-dependent values of fecal calprotectin in cystic fibrosis and healthy children', Journal of Cystic Fibrosis, 16, pp. S41 - S41, http://dx.doi.org/10.1016/s1569-1993(17)30292-8

Garg M; Leach ST; Needham B; Coffey MJ; Katz TE; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY, 2017, 'WS21.1 Determining the age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis during the first decade of life', Journal of Cystic Fibrosis, 16, pp. S34 - S34, http://dx.doi.org/10.1016/s1569-1993(17)30268-0

Alhagamhmad MH; Day AS; Lemberg DA; Leach ST, 2016, 'An overview of the bacterial contribution to Crohn disease pathogenesis', Journal of Medical Microbiology, 65, pp. 1049 - 1059, http://dx.doi.org/10.1099/jmm.0.000331

Su HY; Gupta V; Day AS; Gearry RB, 2016, 'Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand', Inflammatory Bowel Diseases, 22, pp. 2238 - 2244, http://dx.doi.org/10.1097/MIB.0000000000000829

Kaakoush NO; Thomas DS; Ruzayqat MM; Lynch D; Leach ST; Lemberg DA; Day AS; Mitchell HM, 2016, 'Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with firmicutes taxa', Microbiology (United Kingdom), 162, pp. 1388 - 1397, http://dx.doi.org/10.1099/mic.0.000328

Kaakoush NO; Thomas DS; Ruzayqat MM; Lynch D; Leach ST; Lemberg DA; Day AS; Mitchell HM, 2016, 'Campylobacter concisus utilizes blood but not short chain fatty acids despite showing associations with Firmicutes taxa', MICROBIOLOGY-SGM, 162, pp. 1388 - 1397, http://dx.doi.org/10.1099/mic.0.000328

De Voogd FAE; Gearry RB; Mulder CJ; Day AS, 2016, 'Osteoprotegerin: A novel biomarker for inflammatory bowel disease and gastrointestinal carcinoma', Journal of Gastroenterology and Hepatology (Australia), 31, pp. 1386 - 1392, http://dx.doi.org/10.1111/jgh.13324

Kaakoush NO; Day AS; Leach ST; Lemberg DA; Mitchell HM, 2016, 'Reduction in Gut Microbial Diversity as a Mechanism of Action of Exclusive Enteral Nutrition', American Journal of Gastroenterology, 111, pp. 1033, http://dx.doi.org/10.1038/ajg.2016.61

Nielsen S; Needham B; Leach ST; Day AS; Jaffe A; Thomas T; Ooi CY, 2016, 'Disrupted progression of the intestinal microbiota with age in children with cystic fibrosis', Scientific Reports, 6, pp. 24857, http://dx.doi.org/10.1038/srep24857

Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Keenan JI; Leach S; Burgess L; Aitchison A; Gorelik A; Liew D; Day AS; Gearry RB, 2016, 'Comparison of fecal inflammatory markers in Crohn's disease', Inflammatory Bowel Diseases, 22, pp. 1086 - 1094, http://dx.doi.org/10.1097/MIB.0000000000000671

Andre M; Day AS, 2016, 'Causes of prolonged jaundice in infancy: 3-year experience in a tertiary paediatric centre', New Zealand Medical Journal, 129, pp. 14 - 21

Karim S; McCombie A; Day AS; Gearry RB, 2016, '797 Transition Clinics in Inflammatory Bowel Disease: An Observational Study of Patients' Attitude, Views and Concerns', Gastroenterology, 150, pp. S167 - S167, http://dx.doi.org/10.1016/s0016-5085(16)30652-7

Leach ST; Lui K; Naing Z; Dowd SE; Mitchell HM; Day AS, 2015, 'Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis', Digestive Diseases and Sciences, 60, pp. 3728 - 3734, http://dx.doi.org/10.1007/s10620-015-3830-6

Kho A; Whitehead M; Day AS, 2015, 'Coeliac disease in children in Christchurch, New Zealand: Presentation and patterns from 2000-2010.', World J Clin Pediatr, 4, pp. 148 - 154, http://dx.doi.org/10.5409/wjcp.v4.i4.148

Boon GJAM; Day AS; Mulder CJ; Gearry RB, 2015, 'Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?', World Journal of Gastroenterology, 21, pp. 11469 - 11480, http://dx.doi.org/10.3748/wjg.v21.i40.11469

Back to profile page